Webcast/CME - Assuring the Safe and Appropriate Management of Anemia in Two Patient Populations: Cancer and Chronic Kidney Disease

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Anaemia

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Anaemia

Recent news - Anaemia

	Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency - (N Engl J Med)
	Darbepoetin Alfa Risky for Type 2 Diabetics With Kidney Disease: Presented at AHA - (DGDispatch)
	TopAbstracts in Anaemia 11/11/2009 - (DGNews)
	A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia - (N Engl J Med)
	Darbepoetin Alfa Risks Outweigh Benefits for Patients With CKD, Diabetes, and Anaemia: Presented at Renal Week 2009 - (DGDispatch)

Recent cases - Anaemia

	A Fatal Case of Ceftriaxone-Induced Autoimmune Hemolytic Anemia
	A Patient with Haemolytic Anaemia Diagnosed After Thirty Years
	Severe Anemia From Bedbugs
	Orthodontic Management of Traumatic Avulsion of Permanent Incisors in a Child With Sickle Cell Anaemia: A Case Report
	Celiac Disease: It's More Common Than You Think

personal edition > anaemia > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Assuring the Safe and Appropriate Management of Anemia in Two Patient Populations: Cancer and Chronic Kidney Disease

Presented by:	The American Society of Health-System Pharmacists
Lecturer	Howard I. Cohen, M.S., R.Ph., FASHP, Darren W. Grabe, Pharm.D. and Marlo A. Blazer, Pharm.D.
Approximate duration:	2 hrs.
Summary points:	In this interactive educational activity, the authors describe patients at risk for chemotherapy-induced anaemia or anaemia associated with chronic kidney disease, describe the efficacy and safety of available treatment options, and use patient cases to demonstrate options for managing these patients.
Accreditation:	The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 2.0 hours (0.2 CEUs) of continuing education credit (program number 204-000-08-467-H01P). Expiration Date: February 28, 2010.
Other:

Additional Information